Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.
about
Pig peripheral blood mononuclear cells are directly associated with the thrombotic microangiopathy that complicates the induction of chimerism in pig-to-baboon xenotransplantation.Global unresponsiveness as a mechanism of natural killer cell tolerance in mixed xenogeneic chimeras.Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathy.Impact of Mixed Xenogeneic Porcine Hematopoietic Chimerism on Human NK Cell Recognition in a Humanized Mouse ModelMixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejectionOccurrence of specific humoral non-responsiveness to swine antigens following administration of GalT-KO bone marrow to baboons.Acquisition and presentation of follicular dendritic cell-bound antigen by lymph node-resident dendritic cellsHigh incidence of xenogenic bone marrow engraftment in pig-to-baboon intra-bone bone marrow transplantationRat stem cells developing in irradiated SCID mice fail to become tolerized and cause lethal graft-versus-host diseaseSpecific tolerance across a discordant xenogeneic transplantation barrier.Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia ADevelopment and tolerization of hyperacute rejection in a transgenic mouse graft versus host model.The concurrent maturation of mouse and human thymocytes in human fetal thymus implanted in NIH-beige-nude-xid mice is associated with the reconstitution of the murine immune systemHematopoietic cells and radioresistant host elements influence natural killer cell differentiation.Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis.Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioningImmune tolerance: mechanisms and application in clinical transplantation.Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftmentImmunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.Mouse models in bone marrow transplantation and adoptive cellular therapy.Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies.Xenotransplantation: immunological hurdles and progress toward tolerance.Modulation of the in vivo primate anti-Gal response through administration of anti-idiotypic antibodies.Xenograft tolerance.Depletion of IgM xenoreactive natural antibodies by injection of anti-mu monoclonal antibodies.Strategies for tolerance induction to composite tissue allografts.TH1 and TH2 lymphocytes in autoimmunity.Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation.Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease.Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection.The Role of NK Cells in Pig-to-Human Xenotransplantation.American society of transplantation symposium on B cells in transplantation: harnessing humoral immunity from rodent models to clinical practice.T cell-mediated xenograft rejection: specific tolerance is probably required for long term xenograft survival.
P2860
Q31050319-ACA243A7-C95A-480A-B2B6-4E66148A7AEFQ33291223-ED2BD841-79A6-49B9-81EF-A779857798ABQ33338902-C3445AC0-071B-4F62-AA38-0A5DC57558EBQ33629253-A0D99F71-0CED-451A-B449-B456C4CD00D9Q33853565-D5A3AA93-C986-4992-BE1B-C7E77BFCE307Q34140419-A526E1D5-5604-4804-B06B-3099347947B3Q34501458-F56918DF-69BF-404C-8E7D-AB05B9A0F549Q35532677-651DDF3B-1671-4A51-8CD0-E6F8D558374FQ35763831-FE719E40-0038-4F9E-B4ED-29B4EA5EFF67Q35882473-CECA981B-A01E-4707-9A0B-8AD438C21116Q36097677-BE96006A-3F9B-4BAD-AE11-0D5D56A25A37Q36149897-D94DB561-9916-4780-A386-9DA27453C644Q36361449-01DDBAE7-239A-4BF0-B7DA-E4766975EF19Q36361906-B057855F-59C0-4C2C-8606-6CA0A9C1114CQ36400683-BEC95840-2474-4757-9594-03339F4AD3D1Q36466103-E4F4FD48-1C76-4AB7-BA53-6974D854F666Q36733258-2DDB3411-E33C-4859-9F1A-19091DB76491Q36909564-5BBCCA4C-B0D1-403B-B9F0-38C528ADB502Q37211290-BBA49151-7FEF-4BC1-B8A6-AEB3F39FEB3DQ37358501-A0AD37AD-9F18-4A09-A742-BF065568330BQ37634944-4C659EDD-E59A-4B2B-A012-437DB0D5B6A9Q37677563-B0DB39CE-5F3F-4982-BB15-02A8B1222DE7Q37742101-B5F1E5C6-82E0-42C4-8AEA-477009F1C5EDQ38187179-A14E9DCC-BDC0-4700-91F7-67AD194B674AQ38291105-C5F75F81-CFC0-47ED-94A7-A8D3FAECF6C5Q40600287-44A30EAA-84AA-4736-8A01-BA25B88A9170Q40600305-19C91A7F-EB97-4267-AF1E-B3A7EDBC4CD6Q40730555-FF94C8DC-4EF2-43B9-92DD-9A4E36F77EC0Q41039934-B669B159-F26C-4ED8-B7DD-13A67BECE50BQ43011753-D2A0EFC4-F7F0-4CB3-9299-5289C4B54652Q43687563-598F8F7F-BE5A-412D-8AB7-F6CA3EDAAA97Q43916884-C8B8FA6D-F97A-4B57-9176-C696A7F0885BQ48093746-9A2D7117-DD06-4D9E-A902-021E33639CE9Q51101952-6FDBA622-EBFB-4DBD-BEB0-3FD457A67783Q54096418-F74C236E-DDA2-4B8C-A451-05A1DA9497FD
P2860
Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Specific tolerance induction a ...... nonlethal preparative regimen.
@ast
Specific tolerance induction a ...... nonlethal preparative regimen.
@en
type
label
Specific tolerance induction a ...... nonlethal preparative regimen.
@ast
Specific tolerance induction a ...... nonlethal preparative regimen.
@en
prefLabel
Specific tolerance induction a ...... nonlethal preparative regimen.
@ast
Specific tolerance induction a ...... nonlethal preparative regimen.
@en
P2093
P2860
P356
P1476
Specific tolerance induction a ...... nonlethal preparative regimen.
@en
P2093
Aksentijevich I
Sundt TM 3rd
P2860
P304
P356
10.1084/JEM.172.1.195
P407
P577
1990-07-01T00:00:00Z